Answers are grounded in this paper and cite their sources.
Demonstrates low-dose simvastatin promotes autophagy in pancreatic cancer cells, suggesting potential therapeutic implications.
These findings may explain one of the reasons for the suboptimal efficacy of simvastatin in the treatment of pancreatic cancer, while also providing new insights for research on the antitumor effects of statins.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: